TY - JOUR
T1 - An Experimental Model of Nephritis Induced by Calf Serum Injection in Mice
AU - Tsuchimoto, Masahiro
AU - Komoriya, Keiji
AU - Koyama, Tamotsu
AU - Hosoda, Kenji
AU - Takeshita, Toru
AU - Naruchi, Tatsuyuki
AU - Matsuura, Eiji
AU - Yamamoto, Itaru
N1 - Copyright:
Copyright 2016 Elsevier B.V., All rights reserved.
PY - 1984
Y1 - 1984
N2 - Acute glomerulonephritis characterized by proteinuria, hypoalbuminemia and leukocytosis was induced in mice by repeated intraperitoneal injections of calf serum (1 ml/mousex10). In mice treated with calf serum, hypercellularity, karyor rhexis, expansion of the mesangium and hyalinosis in the glomeruli were observed by light microscopy. Furthermore, circulating immune complexes were detected in the serum, and deposits of mouse IgG and C3 on the basement membranes of the glomeruli were demonstrated immunohistochemically. Oral administration of cyclophosphamide or 6-mercaptopurine at a dose of 20 mg/kg/day significantly suppressed the development of this nephritis. Dexamethasone (0.5 mg/kg/day) caused moderate inhibition of the nephritic changes. These results suggest that this experimental model may be useful for evaluation of anti-nephritic drugs.
AB - Acute glomerulonephritis characterized by proteinuria, hypoalbuminemia and leukocytosis was induced in mice by repeated intraperitoneal injections of calf serum (1 ml/mousex10). In mice treated with calf serum, hypercellularity, karyor rhexis, expansion of the mesangium and hyalinosis in the glomeruli were observed by light microscopy. Furthermore, circulating immune complexes were detected in the serum, and deposits of mouse IgG and C3 on the basement membranes of the glomeruli were demonstrated immunohistochemically. Oral administration of cyclophosphamide or 6-mercaptopurine at a dose of 20 mg/kg/day significantly suppressed the development of this nephritis. Dexamethasone (0.5 mg/kg/day) caused moderate inhibition of the nephritic changes. These results suggest that this experimental model may be useful for evaluation of anti-nephritic drugs.
UR - http://www.scopus.com/inward/record.url?scp=0021135532&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021135532&partnerID=8YFLogxK
U2 - 10.1254/jjp.36.223
DO - 10.1254/jjp.36.223
M3 - Article
C2 - 6392653
AN - SCOPUS:0021135532
SN - 0021-5198
VL - 36
SP - 223
EP - 234
JO - Japanese Journal of Pharmacology
JF - Japanese Journal of Pharmacology
IS - 2
ER -